ConductScience.org, home

Paper12445249

P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer.

Sagarra RA and 5 others. Int J Gynecol Cancer, 2002. Cited by 29 papers, by iCite.

Cite this record

ConductScience Library. P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer. Papers, record 12445249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12445249

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer.
PubMed
Journal
Int J Gynecol Cancer
PubMed
Year
2002
PubMed
Publication types
Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
29
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2022-03-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sagarra RAR A M
2Andrade LAL A L A
3Martinez EZE Z
4Pinto GAG A
5Syrjänen KJK J
6Derchain SFS F M

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Ovarian NeoplasmsMajor topic
Proto-Oncogene Proteins c-bcl-2Major topic
Tumor Suppressor Protein p53Major topic
Adenocarcinoma, Mucinous
Adult
Aged
Brazil
Carcinoma, Endometrioid
Cystadenocarcinoma, Papillary
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Humans
Immunohistochemistry
Middle Aged
Multivariate Analysis
Neoplasm Staging
Predictive Value of Tests
Prognosis
Survival Analysis

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.

PMIDTitleJournalYearIn PapersSource
42957658Cell death-based treatment of ovarian cancer.Cell Death Dis2026https://conductscience.org/library/papers/42957658PubMed
29535553Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?Cancer Manag Res2018https://conductscience.org/library/papers/29535553PubMed
29147191Correlation Between Immunohistochemical Biomarkers Expression and Prognosis of Ovarian Carcinomas in Tunisian Patients.World J Oncol2010https://conductscience.org/library/papers/29147191PubMed
24864239Tissue biomarkers in prognostication of serous ovarian cancer following neoadjuvant chemotherapy.Biomed Res Int2014https://conductscience.org/library/papers/24864239PubMed
24281100Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies.Cancers (Basel)2010https://conductscience.org/library/papers/24281100PubMed
24105793Pathway modulations and epigenetic alterations in ovarian tumorbiogenesis.J Cell Physiol2014https://conductscience.org/library/papers/24105793PubMed
24065105The consequence of oncomorphic TP53 mutations in ovarian cancer.Int J Mol Sci2013https://conductscience.org/library/papers/24065105PubMed
23595127Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies.J Cancer Res Clin Oncol2013https://conductscience.org/library/papers/23595127PubMed
22995373
Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors.
Diagn Pathol2012https://conductscience.org/library/papers/22995373PubMed
19513073Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.Br J Cancer2009https://conductscience.org/library/papers/19513073PubMed
19007973Urinary levels of Bcl-2 are elevated in ovarian cancer patients.Gynecol Oncol2009https://conductscience.org/library/papers/19007973PubMed
17594113Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma.Virchows Arch2007https://conductscience.org/library/papers/17594113PubMed
16720921The value of serum bcl-2 levels in advanced epithelial ovarian cancer.Med Oncol2006https://conductscience.org/library/papers/16720921PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12445249

GET https://conductscience.org/api/papers/v1/12445249/authors